Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.

Jing-Hua ChenXiang-Peng ChuJia-Tao ZhangQiang NieWen-Fang TangJian SuHong-Hong YanHong-Ping ZhengZe-Xin ChenXin ChenMeng-Meng SongXin YiPan-Song LiYan-Fang GuanGang LiChu-Xia DengRafael RosellYi-Long WuWen-Zhao Zhong

Published in: Thoracic cancer (2020)

Lung cancer organoid models could save precious time of drug testing on patients, and accurately select anticancer drugs according to the drug sensitivity results, so as to provide a powerful supplement and verification for the gene sequencing.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
gene expression
drug induced
single cell
dna methylation